Weiyuan Yuan Selected Research

yu ping feng san

11/2019	Huangqi-Fangfeng protects against allergic airway remodeling through inhibiting epithelial-mesenchymal transition process in mice via regulating epithelial derived TGF-β1.
1/2019	A Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma Recurrence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiyuan Yuan Research Topics

Disease

4	Inflammation (Inflammations) 02/2021 - 11/2019
2	Atopic Dermatitis (Atopic Eczema) 02/2021 - 11/2019
2	Asthma (Bronchial Asthma) 01/2021 - 01/2019
1	Airway Remodeling 11/2019
1	Respiratory Hypersensitivity 01/2019
1	Infections 01/2018

Drug/Important Bio-Agent (IBA)

2	AllergensIBA 11/2019 - 11/2019
2	yu ping feng sanIBA 11/2019 - 01/2019
1	Estrogen ReceptorsIBA 02/2021
1	Flavin Mononucleotide (FMN)IBA 02/2021
1	GTP-Binding Proteins (G-Protein)IBA 02/2021
1	formononetinIBA 02/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	FangfengIBA 11/2019
1	Huang QiIBA 11/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Interleukin-13IBA 01/2019
1	montelukast (Singulair)FDA Link 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2019
1	Interleukin-5 (Interleukin 5)IBA 01/2019
1	CytokinesIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Antimicrobial PeptidesIBA 01/2018